Chemoinformaics analysis of DIHYDROPALUSTRIC-ACID
| Molecular Weight | 246.262 | nRot | 5 |
| Heavy Atom Molecular Weight | 232.15 | nRig | 9 |
| Exact Molecular Weight | 246.089 | nRing | 1 |
| Solubility: LogS | -3.473 | nHRing | 1 |
| Solubility: LogP | 3.314 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 32 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 5 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 5 |
| nHA | 3 | APOL | 35.9231 |
| nHD | 1 | BPOL | 17.5169 |
| QED | 0.285 |
| Synth | 2.907 |
| Natural Product Likeliness | 0.685 |
| NR-PPAR-gamma | 0.857 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.003 |
| HIA | 0.067 |
| CACO-2 | -4.556 |
| MDCK | 0.0000149 |
| BBB | 0.014 |
| PPB | 0.979573 |
| VDSS | 0.832 |
| FU | 0.0125048 |
| CYP1A2-inh | 0.427 |
| CYP1A2-sub | 0.169 |
| CYP2c19-inh | 0.4 |
| CYP2c19-sub | 0.06 |
| CYP2c9-inh | 0.883 |
| CYP2c9-sub | 0.853 |
| CYP2d6-inh | 0.015 |
| CYP2d6-sub | 0.203 |
| CYP3a4-inh | 0.02 |
| CYP3a4-sub | 0.114 |
| CL | 1.462 |
| T12 | 0.791 |
| hERG | 0.019 |
| Ames | 0.674 |
| ROA | 0.698 |
| SkinSen | 0.937 |
| Carcinogencity | 0.829 |
| EI | 0.951 |
| Respiratory | 0.96 |
| NR-Aromatase | 0.285 |
| Antiviral | No |
| Prediction | 0.582805 |